AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 81 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $478,000 | +0.6% | 60,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $475,000 | -1.2% | 60,300 | -11.1% | 0.00% | 0.0% |
| Q3 2020 | $481,000 | +58.7% | 67,800 | +70.8% | 0.00% | 0.0% |
| Q4 2019 | $303,000 | +100.7% | 39,700 | +102.8% | 0.00% | – |
| Q3 2019 | $151,000 | 0.0% | 19,573 | -11.4% | 0.00% | – |
| Q2 2019 | $151,000 | -13.2% | 22,100 | +2.3% | 0.00% | – |
| Q1 2019 | $174,000 | +39.2% | 21,600 | +29.3% | 0.00% | – |
| Q4 2018 | $125,000 | – | 16,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $258,000 | 3.49% |
| Aisling Capital Management LP | 1,691,151 | $3,890,000 | 2.10% |
| Sio Capital Management, LLC | 871,101 | $2,004,000 | 0.66% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $6,550,000 | 0.64% |
| Samsara BioCapital, LLC | 883,720 | $2,033,000 | 0.51% |
| Ghost Tree Capital, LLC | 686,599 | $1,579,000 | 0.34% |
| Nantahala Capital Management | 3,200,593 | $7,361,000 | 0.33% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $565,000 | 0.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,059,894 | $9,338,000 | 0.28% |
| Lion Point Capital, LP | 300,000 | $690,000 | 0.16% |